Latest News & Updates

Breaking News

46 minutes ago
Pharma Now Editorial Team

CDSCO Replaces Approval Gate with Digital Intimation for Early Drug Testing

Merck Re-enters PD Contention as AACR 2026 Reshapes Lung Cancer Pipeline

Pharma Now Editorial Team

Lilly's $7B Kelonia Deal Reshapes In Vivo CAR-T Supply Chains

Pharma Now Editorial Team

FDA Accepts Roche sBLA for Obinutuzumab in SLE, Decision Due December 2026

Pharma Now Editorial Team

Allogene Advances Dual-Target CAR T Strategy in Multiple Myeloma

Pharma Now Editorial Team

Other trending news you may like to read

CDSCO Replaces Approval Gate with Digital Intimation for Early Drug Testing

CDSCO shifts early drug testing entry from formal approval to digital prior intimation via the NSWS portal, compressing timelines for sponsors and CDMOs.

Pharma Now Editorial Team

Merck Re-enters PD Contention as AACR 2026 Reshapes Lung Cancer Pipeline

Merck's pumitamig update at AACR 2026 signals renewed PD-pathway competition, with manufacturing and CMC implications for late-stage oncology pipelines.

Pharma Now Editorial Team

Lilly's $7B Kelonia Deal Reshapes In Vivo CAR-T Supply Chains

Eli Lilly acquires Kelonia Therapeutics for $7B, securing in vivo CAR-T capabilities and signaling a shift in ATMP manufacturing strategy.

Pharma Now Editorial Team

FDA Accepts Roche sBLA for Obinutuzumab in SLE, Decision Due December 2026

FDA accepts Roche sBLA for obinutuzumab in SLE based on ALLEGORY phase III data; decision expected December 2026.

Pharma Now Editorial Team